resveratrol has been researched along with Auricular Fibrillation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, ED; Garavaglia, J; Marcadenti, A; Markoski, MM; Stephan, LS | 1 |
| Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kochhäuser, S; Wolfes, J | 1 |
| Li, Y; Liu, Z; Sheng, L; Yuan, Y; Zhang, S; Zhang, Y; Zhao, X | 1 |
| Dobrev, D; Heijman, J; Sutanto, H | 1 |
| Baczko, I; Dolinsky, V; Dyck, JR; Hall, D; Hamming, KC; Husti, Z; Jaeger, K; Juhasz, V; Klausz, G; Light, PE; Liknes, D; Pap, R; Rauniyar, V; Saghy, L; Searle, G; Varro, A; Wang, S; Yang, W | 1 |
| Chang, SL; Chen, SA; Chen, YC; Chen, YJ; Chong, E; Higa, S; Hsiao, YW; Hsu, CP; Leha, T; Lin, WY; Liu, SH; Singhal, R; Wu, TJ | 1 |
| Baczkó, I; Light, PE | 1 |
2 review(s) available for resveratrol and Auricular Fibrillation
| Article | Year |
|---|---|
Red Wine, Resveratrol and Atrial Fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Atrial Fibrillation; Humans; Myocytes, Cardiac; Polyphenols; Resveratrol; Stilbenes; Wine | 2017 |
Resveratrol and derivatives for the treatment of atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiotonic Agents; Humans; Resveratrol; Stilbenes | 2015 |
5 other study(ies) available for resveratrol and Auricular Fibrillation
| Article | Year |
|---|---|
Acute electrophysiologic effects of the polyphenols resveratrol and piceatannol in rabbit atria.
Topics: Animals; Atrial Fibrillation; Atrial Function; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Heart Atria; Rabbits; Resveratrol; Stilbenes | 2019 |
Resveratrol prevents atrial fibrillation by inhibiting atrial structural and metabolic remodeling in collagen-induced arthritis rats.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Anti-Arrhythmia Agents; Arthritis, Experimental; Atrial Fibrillation; Atrial Remodeling; Female; Fibrosis; Glycogen; Heart Atria; Interleukin-6; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Kinases; Rats, Wistar; Resveratrol; Tumor Necrosis Factor-alpha | 2018 |
Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation?
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Inflammation; Resveratrol | 2018 |
Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.
Topics: Action Potentials; Adult; Aged; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Antioxidants; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Excitation Contraction Coupling; G Protein-Coupled Inwardly-Rectifying Potassium Channels; HEK293 Cells; Humans; Kv1.5 Potassium Channel; Male; Middle Aged; Myocardial Contraction; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; NFATC Transcription Factors; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Resveratrol; Sodium Channel Blockers; Stilbenes; Transfection | 2014 |
Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation.
Topics: Androstadienes; Animals; Antioxidants; Atrial Fibrillation; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Nitric Oxide Synthase Type III; Onium Compounds; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rabbits; Resveratrol; Signal Transduction; Stilbenes; Wine; Wortmannin | 2015 |